Research in Dermatology

Stanford EB Research

Epidermolysis bullosa (EB) is a rare genetic skin disorder that causes extreme skin fragility, leading to recurrent blister formation with even minor trauma. There are three major forms of EB: EB simplex (EBS), Junctional EB (JEB), and Dystrophic EB (DEB). Each type of EB differs in severity and clinical presentation. Caring for all patients with EB requires a multidisciplinary approach.

Clinical Trials

Stanford Dermatology Department's clinical trials unit is home to 12-15 ongoing clinical studies, investigating the safety and efficacy of new and currently available drugs and over-the-counter medications.  The  unit works with Stanford's own panel on medical research, leading pharmaceutical companies,and the Food and Drug Administration to safely and ethically expand the medical field's knowledge of dermatologic treatments.  New studies begin regularly, and the unit continues to recruit patients with skin aging, sun damage, skin cancer (including basal cell carcinomas), psoriasis, atopic dermatitis, rosacea, and other dermatologic diseases for ongoing studies.

Faculty Labs

Research in the Department of Dermatology span a wide range of efforts, ranging from clinical trials to molecular translational medicine to fundamental studies in epithelial biology, as embodied in the Stanford Program in Epithelial Biology.

Research links